1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
2 Institute for Healthcare Policy and Innovation.
Ann Am Thorac Soc. 2017 Jun;14(6):943-951. doi: 10.1513/AnnalsATS.201611-847OC.
Admission to an intensive care unit (ICU) may be beneficial to patients with pneumonia with uncertain ICU needs; however, evidence regarding the association between ICU admission and mortality for other common conditions is largely unknown.
To estimate the relationship between ICU admission and outcomes for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD), exacerbation of heart failure (HF), or acute myocardial infarction (AMI).
We performed a retrospective cohort study of all acute care hospitalizations from 2010 to 2012 for U.S. fee-for-service Medicare beneficiaries aged 65 years and older admitted with COPD exacerbation, HF exacerbation, or AMI. We used multivariable adjustment and instrumental variable analysis to assess each condition separately. The instrumental variable analysis used differential distance to a high ICU use hospital (defined separately for each condition) as an instrument for ICU admission to examine marginal patients whose likelihood of ICU admission depended on the hospital to which they were admitted. The primary outcome was 30-day mortality. Secondary outcomes included hospital costs.
Among 1,555,798 Medicare beneficiaries with COPD exacerbation, HF exacerbation, or AMI, 486,272 (31%) were admitted to an ICU. The instrumental variable analysis found that ICU admission was not associated with significant differences in 30-day mortality for any condition. ICU admission was associated with significantly greater hospital costs for HF ($11,793 vs. $9,185, P < 0.001; absolute increase, $2,608 [95% confidence interval, $1,377-$3,840]) and AMI ($19,513 vs. $14,590, P < 0.001; absolute increase, $4,922 [95% confidence interval, $2,665-$7,180]), but not for COPD.
ICU admission did not confer a survival benefit for patients with uncertain ICU needs hospitalized with COPD exacerbation, HF exacerbation, or AMI. These findings suggest that the ICU may be overused for some patients with these conditions. Identifying patients most likely to benefit from ICU admission may improve health care efficiency while reducing costs.
入住重症监护病房(ICU)可能对需要 ICU 治疗但情况尚不确定的肺炎患者有益;然而,对于其他常见疾病,入住 ICU 与死亡率之间的关联证据尚不清楚。
评估 ICU 收治与慢性阻塞性肺疾病(COPD)加重、心力衰竭(HF)加重或急性心肌梗死(AMI)住院患者结局之间的关系。
我们对 2010 年至 2012 年期间所有因 COPD 加重、HF 加重或 AMI 入住美国按服务收费医疗保险(Medicare)的 65 岁及以上患者进行了回顾性队列研究。我们使用多变量调整和工具变量分析分别评估每种情况。工具变量分析采用 ICU 使用量高的医院的差异距离(分别针对每种情况进行定义)作为 ICU 收治的工具变量,以评估那些收治医院决定其 ICU 收治可能性的边缘患者。主要结局为 30 天死亡率。次要结局包括医院费用。
在 1555798 名因 COPD 加重、HF 加重或 AMI 入住 Medicare 的患者中,有 486272 名(31%)入住 ICU。工具变量分析发现,对于任何一种疾病,入住 ICU 与 30 天死亡率的显著差异均无相关性。入住 ICU 与 HF($11793 比 $9185,P<0.001;绝对增加,$2608[95%置信区间,$1377-$3840])和 AMI($19513 比 $14590,P<0.001;绝对增加,$4922[95%置信区间,$2665-$7180])的住院费用显著增加相关,但与 COPD 无关。
对于入住 ICU 治疗的 COPD 加重、HF 加重或 AMI 但 ICU 需求不确定的患者,入住 ICU 并不能带来生存获益。这些发现表明,对于某些患有这些疾病的患者,ICU 的使用可能过度。确定最有可能从 ICU 收治中获益的患者可能会提高医疗保健效率,同时降低成本。